Status:
COMPLETED
Usual Care Intervention Research Evaluating the Impact of a Personalized Pharmaceutical Plan on the Duration of Opioid Treatment in Non-cancerous Pain
Lead Sponsor:
University Hospital, Rouen
Conditions:
Non-cancerous Pain
Opioid Use
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Many treatments with WHO grade III opioids are being introduced in the rheumatology department for non-cancerous pain. The duration of this treatment prescribed at discharge is often uncontrolled and ...
Eligibility Criteria
Inclusion
- Age ≥ 18 and \< 75 years old when entering the rheumatology department
- Hospitalization in the rheumatology department
- Patient with acute non-traumatic musculoskeletal disease
- Patient not taking grade III opioid treatment
- Patient affiliated to a social security scheme
- Patient having read and understood the information letter and signed the consent form
- Patient present on a day which the pharmacy intern is present
Exclusion
- Presence of cancer, fibromyalgia, already diagnosed at inclusion
- Patient does not understand French
- Patient with Current or past opioid addiction
- Person deprived of liberty by administrative or judicial decision
Key Trial Info
Start Date :
August 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05196386
Start Date
August 6 2020
End Date
August 28 2023
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rouen University Hospital
Rouen, France